Thyroid Cancer: 32 (Endocrine Updates, 32) - Hardcover
The American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women. The overall 5-year survival rate is about 97%, making it one of the least lethal cancers. We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroid nodules and microcarcinomas. Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer. Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In Thyroid Cancer, a renowned group of authors presents a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. State-of-the-art and a significant contribution to the literature, Thyroid Cancer is an invaluable reference for endocrinologists, oncologists, nuclear medicine physicians, radiation oncologists, primary care physicians, and surgeons who deal with head and neck cancer.
"synopsis" may belong to another edition of this title.
Review:
From the reviews:
“The book is appropriate for practitioners involved in the care of patients with thyroid cancer, including internists, endocrinologists, surgeons, oncologists, radiologists, radiation oncologists, and pathologists. Students and housestaff officers with a particular interest in thyroid cancer also may find this book useful. ... This is a comprehensive book on thyroid cancer with short and succinct chapters, making it very readable. It will be of interest to those who want to learn more about advances in thyroid cancer diagnosis and management.” (Rebecca L. Brown, Doody’s Review Service, March, 2012)"About this title" may belong to another edition of this title.
- PublisherSpringer
- Publication date2011
- ISBN 10 1461408741
- ISBN 13 9781461408741
- BindingHardcover
- Number of pages332
- EditorBraunstein Glenn D.
Buy New
Learn more about this copy
£ 166.38
Shipping:
FREE
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Seller Image
Thyroid Cancer (Endocrine Updates) [Hardcover ]
Seller:
Rating
Book Description Hardcover. Condition: new. Seller Inventory # 9781461408741
Buy New
£ 166.38
Convert currency
Seller Image
Thyroid Cancer
Published by
Springer US
(2011)
ISBN 10: 1461408741
ISBN 13: 9781461408741
New
Hardcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # 4196955
Buy New
£ 169.79
Convert currency
Seller Image
Buy New
£ 215.87
Convert currency
Stock Image
Thyroid Cancer (Endocrine Updates, 32)
Published by
Springer
(2011)
ISBN 10: 1461408741
ISBN 13: 9781461408741
New
Hardcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Mar2716030035177
Buy New
£ 216.56
Convert currency
Seller Image
Thyroid Cancer
Published by
Springer US Nov 2011
(2011)
ISBN 10: 1461408741
ISBN 13: 9781461408741
New
Hardcover
Quantity: 2
Seller:
Rating
Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women. The overall 5-year survival rate is about 97%, making it one of the least lethal cancers. We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroid nodules and microcarcinomas. Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer. Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In Thyroid Cancer, a renowned group of authors presents a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. State-of-the-art and a significant contribution to the literature, Thyroid Cancer is an invaluable reference for endocrinologists, oncologists, nuclear medicine physicians, radiation oncologists, primary care physicians, and surgeons who deal with head and neck cancer. 332 pp. Englisch. Seller Inventory # 9781461408741
Buy New
£ 207.51
Convert currency
Seller Image
Buy New
£ 216.55
Convert currency
Seller Image
Thyroid Cancer
Published by
Springer US
(2011)
ISBN 10: 1461408741
ISBN 13: 9781461408741
New
Hardcover
Quantity: 1
Seller:
Rating
Book Description Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women. The overall 5-year survival rate is about 97%, making it one of the least lethal cancers. We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroid nodules and microcarcinomas. Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer. Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In Thyroid Cancer, a renowned group of authors presents a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. State-of-the-art and a significant contribution to the literature, Thyroid Cancer is an invaluable reference for endocrinologists, oncologists, nuclear medicine physicians, radiation oncologists, primary care physicians, and surgeons who deal with head and neck cancer. Seller Inventory # 9781461408741
Buy New
£ 210
Convert currency